Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news
Pfizer says inhaled insulin is effective
SAN DIEGO, Jun 15, 2005 (United Press International via COMTEX) -- Drug maker Pfizer says Exubera, an inhaled insulin powder it is developing, worked as well in a study of 226 patients as injectable insulin.
The company presented its findings at the American Diabetes Association Scientific Sessions conference in San Diego, the New York Times reported Wednesday.
Participating in Exubera's development are two other companies, Sanofi-Aventis and Nektar Therapeutics.
Pfizer also said other studies also showed that Exubera was well tolerated and provided effective control of blood sugar, the Times reported.
Insulin, which diabetics use to control blood sugar, must now be injected, sometimes more than once a day.
The studies appeared to leave open the question of whether Exubera can damage the lungs, an issue that has slowed the drug's approval, the Times said. Pfizer said only that the studies showed patients "experienced no clinically important effects on pulmonary function" but did not define "clinically important effects," said the report.